Bisaryl cyclobutenes derivatives as cyclooxygenase inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Hydrocarbon doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

568 31, A61K 3110, C07C31710

Patent

active

058177000

ABSTRACT:
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.

REFERENCES:
patent: 3335195 (1967-08-01), Freedman et al.
patent: 4967002 (1990-10-01), Pain
patent: 5077142 (1991-12-01), Sakon et al.
Lawson, et al, Journal of Medicinal Chemistry, vol. 17, No. 4, Apr. 1974 "Diarylcyclobutane Analogs of Diethylstilbestrol" pp. 383-386.
Friesen, R.W. et al.: Novel 1,2-diaxylcyclobutenes Selective and orally active CoX-2 inhibitors.
Bioorganic & Medicinal Chemistry Letters, vol. 6, No. 22, pp. 2677-2682, 1996.
Paull, K. D. et al. Cancer Res. vol. 52, No. 14, pp. 3892-3900 (1992).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Bisaryl cyclobutenes derivatives as cyclooxygenase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bisaryl cyclobutenes derivatives as cyclooxygenase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bisaryl cyclobutenes derivatives as cyclooxygenase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-77789

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.